Zhang Qian
SEC CIK 1937484 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GNLX | GENELUX Corp | Associate VP, Research | 139.3K | $1,250 | — | 2 | 2023-01-26 | 2023-02-17 |
Most active insiders at GNLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zindrick Thomas | Pres, CEO | — | $117.7K |
| 2 | Thomas John | Dir | — | $108.8K |
| 3 | Smither John W | Dir | — | $34.9K |
| 4 | Cappello Joseph | Chief Technical Off | — | $34.0K |
| 5 | Yu Yong | SVP, Clinical Development | — | $32.6K |
| 6 | Smalling Ralph | Head of Regulatory | — | $2,804 |
| 7 | Pulisic Matthew | CFO | — | — |
| 8 | Mirabelli Mary | Dir | — | — |
| 9 | Groen Eric | GC | — | — |
| 10 | Tyree James L | Dir | — | — |
Zhang Qian made no open-market trades at GNLX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-02 | 2023-02-17 | GNLX | GENELUX Corp | Zhang Qian | Associate VP, Research | A - Grant | $0.00 | +6,000 | 139.3K | +5% | $0 | |
| I | 2023-01-31 | 2023-01-26 | GNLX | GENELUX Corp | Zhang Qian | Associate VP, Research | P - Purchase | $6.25 | +200 | 200 | New | +$1,250 |
Purchase Sale Sale after option exercise All abbreviations